What is the size of Pharmacovigilance Market?
According to 6Wresearch internal database and industry insights, the
Global Pharmacovigilance Market was valued at USD 7.8 Billion in 2024 and is expected to reach USD 13.5 Billion by 2031, growing at a compound annual growth rate of 8.40% during the forecast period (2025-2031).
The main drivers of this growth are the increasing regulatory and compliance focus on drug safety and adverse-event monitoring, the rising outsourcing of pharmacovigilance services by pharmaceutical firms, and the growing deployment of AI and analytics in signal detection and real-world evidence generation.
Growth Factors for Pharmacovigilance Industry
- Growing interest in outsourced pharmacovigilance services as regulatory burden increases.
- Demand for pharmacovigilance solutions is being driven by the rising number of drug approvals and post-market surveillance requirements.
- Popularity among biotech and pharma companies due to its positive impact on patient safety and brand credibility.
- Expansion of digital monitoring, automated adverse-event analytics and large-scale data capture across treatment populations.
- Innovation in cloud-based safety-databases, AI-driven signal detection tools and integrated risk-management platforms.
Pharmacovigilance Market Trends
The trends in the Pharmacovigilance Market include increased uptake of integrated drug-safety platforms adverse-event reporting, signal detection and risk-management workflows. Service providers are moving into emerging regions and creating hybrid in-house/outsourced models. Additionally, demand is increasing for real-world data and analytics-led pharmacovigilance, as automated and AI-based solutions gain momentum along with regulatory alignment and end-to-end lifecycle safety oversight.
Emerging Developments in the Pharmacovigilance Market
The developments in the Pharmacovigilance Market include launching new modular platforms that utilise AI, natural language processing and analytics to improve case-processing and signal-detection workflows. Companies are increasingly offering end-to-end pharmacovigilance turnkey services, from pre-approval to post-marketing. Heightened regulatory scrutiny and complexity of therapeutic portfolios are causing providers to expand into emerging markets and invest in data infrastructure that can be scaled.
List of Leading Companies in the Pharmacovigilance Market
Some of the leading companies include:
- IQVIA Services Inc.
- ICON plc
- Parexel International Corporation
- PAREXEL International Corporation
- Syneos Health, Inc.
- Wipro Limited (Global PHARMA Services)
- Cognizant Technology Solutions Corporation
Frequently Asked Questions About the Market Study (FAQs):
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on
sales@6wresearch.com